Home /Research /Cell/Bacteria‐Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy (Adv. Mater. 50/2021)
OTHER

Cell/Bacteria‐Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy (Adv. Mater. 50/2021)

Hong Pan, Mingbin Zheng, Ai-Qing Ma, Lanlan Liu, Lintao Cai

Year
2021
Citations
2

Abstract

Personalized Cancer Therapy Cell/bacteria-derived materials with unique bioactive properties have emerged as attractive tools for personalized cancer therapy. In article number 2100241, Lintao Cai and co-workers summarize recent advances of novel approaches for bioinspired and biomimetic precision medicine strategies based on cell/bacteria-derived bioactive materials, along with a series of successful case studies on tiny robots derived from cells/bacteria.

Keywords

Cancer therapyBacteriaMaterials scienceNanotechnologyCancer cellPersonalized medicineImmune systemCancerCancer researchBiology

Related papers

Browse all OTHER papers